Initiation of acute pancreatitis in mice is independent of fusion between lysosomes and zymogen granules
- PMID: 38709385
- PMCID: PMC11074023
- DOI: 10.1007/s00018-024-05247-7
Initiation of acute pancreatitis in mice is independent of fusion between lysosomes and zymogen granules
Abstract
The co-localization of the lysosomal protease cathepsin B (CTSB) and the digestive zymogen trypsinogen is a prerequisite for the initiation of acute pancreatitis. However, the exact molecular mechanisms of co-localization are not fully understood. In this study, we investigated the role of lysosomes in the onset of acute pancreatitis by using two different experimental approaches. Using an acinar cell-specific genetic deletion of the ras-related protein Rab7, important for intracellular vesicle trafficking and fusion, we analyzed the subcellular distribution of lysosomal enzymes and the severity of pancreatitis in vivo and ex vivo. Lysosomal permeabilization was performed by the lysosomotropic agent Glycyl-L-phenylalanine 2-naphthylamide (GPN). Acinar cell-specific deletion of Rab7 increased endogenous CTSB activity and despite the lack of re-distribution of CTSB from lysosomes to the secretory vesicles, the activation of CTSB localized in the zymogen compartment still took place leading to trypsinogen activation and pancreatic injury. Disease severity was comparable to controls during the early phase but more severe at later time points. Similarly, GPN did not prevent CTSB activation inside the secretory compartment upon caerulein stimulation, while lysosomal CTSB shifted to the cytosol. Intracellular trypsinogen activation was maintained leading to acute pancreatitis similar to controls. Our results indicate that initiation of acute pancreatitis seems to be independent of the presence of lysosomes and that fusion of lysosomes and zymogen granules is dispensable for the disease onset. Intact lysosomes rather appear to have protective effects at later disease stages.
Keywords: Acute pancreatitis; Cathepsin B; Co-localization; Lysosome; Secretory vesicle; Trypsinogen.
© 2024. The Author(s).
Conflict of interest statement
All authors declared that there are no conflicts of interest.
Figures






Similar articles
-
Cathepsin D regulates cathepsin B activation and disease severity predominantly in inflammatory cells during experimental pancreatitis.J Biol Chem. 2018 Jan 19;293(3):1018-1029. doi: 10.1074/jbc.M117.814772. Epub 2017 Dec 11. J Biol Chem. 2018. PMID: 29229780 Free PMC article.
-
Cathepsin B-Mediated Activation of Trypsinogen in Endocytosing Macrophages Increases Severity of Pancreatitis in Mice.Gastroenterology. 2018 Feb;154(3):704-718.e10. doi: 10.1053/j.gastro.2017.10.018. Epub 2018 Jan 10. Gastroenterology. 2018. PMID: 29079517 Free PMC article.
-
Missorting of cathepsin B into the secretory compartment of CI-MPR/IGFII-deficient mice does not induce spontaneous trypsinogen activation but leads to enhanced trypsin activity during experimental pancreatitis--without affecting disease severity.J Physiol Pharmacol. 2010 Oct;61(5):565-75. J Physiol Pharmacol. 2010. PMID: 21081800
-
Roles of Autophagy and Pancreatic Secretory Trypsin Inhibitor in Trypsinogen Activation in Acute Pancreatitis.Pancreas. 2020 Apr;49(4):493-497. doi: 10.1097/MPA.0000000000001519. Pancreas. 2020. PMID: 32282761 Review.
-
The role of cysteine proteases in intracellular pancreatic serine protease activation.Adv Exp Med Biol. 2000;477:403-11. doi: 10.1007/0-306-46826-3_41. Adv Exp Med Biol. 2000. PMID: 10849766 Review.
Cited by
-
Hydrogel Innovations in Biosensing: A New Frontier for Pancreatitis Diagnostics.Bioengineering (Basel). 2025 Mar 3;12(3):254. doi: 10.3390/bioengineering12030254. Bioengineering (Basel). 2025. PMID: 40150718 Free PMC article. Review.
-
Akkermansia Muciniphila Alleviates Severe Acute Pancreatitis via Amuc1409-Ube2k-Foxp3 Axis in Regulatory T Cells.Adv Sci (Weinh). 2025 Aug;12(30):e04214. doi: 10.1002/advs.202504214. Epub 2025 Jun 4. Adv Sci (Weinh). 2025. PMID: 40464424 Free PMC article.
-
Phospholipase D2: A biomarker implicated in various pancreatic diseases beyond acute pancreatitis.World J Gastroenterol. 2025 Jul 28;31(28):108271. doi: 10.3748/wjg.v31.i28.108271. World J Gastroenterol. 2025. PMID: 40741474 Free PMC article.
-
From micro to macro, nanotechnology demystifies acute pancreatitis: a new generation of treatment options emerges.J Nanobiotechnology. 2025 Jan 29;23(1):57. doi: 10.1186/s12951-025-03106-6. J Nanobiotechnology. 2025. PMID: 39881355 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous